Skip to contentP
Pure Bioscience, Inc.
P
PUREPure Bioscience, Inc. Q3 2017 · 10-Q
Revenue$338.00K$338.00K−16.1% vs Q3 2016 Net Income-$1.74M-$1.74MN/M vs Q3 2016 EPS Diluted-$0.03-$0.03N/M vs Q3 2016 Operating Income-$1,593,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pure Bioscience, Inc. · CIK 1006028 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$1,203,000N/M Margins · derivedOperating margin-471.3%−101.8 pt vs Q3 2016
Net margin-514.2%−521.6 pt vs Q3 2016
ended Apr 30, 2017 · filed Jun 8, 2017 · 39 d after period end